FindMyRecallSubscribe
Class III: unlikely to cause harmTerminated

Apotex Olanzapine Orally Disintegrating Tablets 5 mg Recall

Olanzapine Orally Disintegrating Tablets 5 mg, 30-count Bottle, Rx only, Manufactured b…

Apotex Corp. · Weston, FL

Risk level
Class III
Reported by FDA
Oct 1, 2014
Recall ID
D-1609-2014
Check your lot numberHow we source this data

Summary

Apotex recalled Olanzapine Orally Disintegrating Tablets 5 mg starting Apr 18, 2014. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-1609-2014 on Oct 1, 2014. Reason: Subpotent Drug: Out of specification (OOS) results at the 9 month temperature point. Status: Terminated.

Why it was recalled

Subpotent Drug: Out of specification (OOS) results at the 9 month temperature point.

Product description

Olanzapine Orally Disintegrating Tablets 5 mg, 30-count Bottle, Rx only, Manufactured by Apotex Inc. Toronto, Ontario Canada M9L1T9, Manufactured for Apotex Corp., Weston, Florida 33326, NDC # 60505-3275-03

Lot numbers, UPCs & expiration codes

Lot # KM4951; Exp. 04/15

Where it was sold

Nationwide.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1609-2014
Classification
Class III
Status
Terminated
Recall initiated
Apr 18, 2014
FDA report date
Oct 1, 2014
Quantity
5,397 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Apotex Corp.

Original FDA data

Every field from FDA enforcement report D-1609-2014, exactly as published.

Show all FDA fields
City
Weston
State
FL
Status
Terminated
Country
United States
Event ID
69177
Address
2400 N Commerce Pkwy Ste 400
Code information
Lot # KM4951; Exp. 04/15
Postal code
33326-3253
Report date
Oct 1, 2014
Product type
Drugs
Recall number
D-1609-2014
Classification
Class III
Recalling firm
Apotex Corp.
Product quantity
5,397 bottles
Termination date
Apr 7, 2017
Reason for recall
Subpotent Drug: Out of specification (OOS) results at the 9 month temperature point.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Olanzapine Orally Disintegrating Tablets 5 mg, 30-count Bottle, Rx only, Manufactured by Apotex Inc. Toronto, Ontario Canada M9L1T9, Manufactured for Apotex Corp., Weston, Florida 33326, NDC # 60505-3275-03
Distribution pattern
Nationwide.
Recall initiation date
Apr 18, 2014
Initial firm notification
Letter
Center classification date
Sep 24, 2014

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1609-2014, published Oct 1, 2014. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls